Ma Z - Search Results

1

Mutation tracking of a patient with EGFR-mutant lung cancer harboring de novo MET amplification: Successful treatment with gefitinib and crizotinib.

Zheng X, Zhang G, Li P, Zhang M, Yan X, Zhang X, Yang J, Li H, Liu X, Ma Z, Wang H. Zheng X, et al. Among authors: ma z. Lung Cancer. 2019 Mar;129:72-74. doi: 10.1016/j.lungcan.2019.01.009. Epub 2019 Jan 23. Lung Cancer. 2019. PMID: 30797494

2

Erlotinib-based perioperative adjuvant therapy for a case of unresectable stage IIIA (N2) nonsmall cell lung cancer.

Wang Q, Wang H, Li P, Zhu H, He C, Wei B, Ma J, Ma Z. Wang Q, et al. Among authors: ma j, ma z. Am J Med Sci. 2010 Oct;340(4):321-5. doi: 10.1097/MAJ.0b013e3181e59ac2. Am J Med Sci. 2010. PMID: 20601859

3

[Research progresses of albumin-bound paclitaxel in the treatment of non-small cell lung cancer].

Li P, Wang Q, Wang H, Ma Z. Li P, et al. Among authors: ma z. Zhongguo Fei Ai Za Zhi. 2010 Jul;13(7):748-52. doi: 10.3779/j.issn.1009-3419.2010.07.16. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20673493 Free PMC article. Review. Chinese. No abstract available.

4

[The role of adjuvant chemotherapy in operable non-small cell lung cancer].

Yan X, Zhu H, Wang H, Wang Q, Li P, Ma Z. Yan X, et al. Among authors: ma z. Zhongguo Fei Ai Za Zhi. 2011 Mar;14(3):281-5. doi: 10.3779/j.issn.1009-3419.2011.03.15. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21426675 Free PMC article. Review. Chinese.

5

[A new target in non-small cell lung cancer: EML4-ALK fusion gene].

Wang H, Yuan J, Ma Z. Wang H, et al. Among authors: ma z. Zhongguo Fei Ai Za Zhi. 2011 Jun;14(6):538-42. doi: 10.3779/j.issn.1009-3419.2011.06.11. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21645460 Free PMC article. Review. Chinese.

6

MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment.

Wang Q, Wang S, Wang H, Li P, Ma Z. Wang Q, et al. Among authors: ma z. Exp Biol Med (Maywood). 2012 Mar;237(3):227-35. doi: 10.1258/ebm.2011.011192. Epub 2012 Feb 16. Exp Biol Med (Maywood). 2012. PMID: 22345301 Review.

7

Differential efficacy of gefitinib across age groups in treatment of advanced lung adenocarcinoma.

Wang H, Zhang G, Li P, Yan X, Wang Q, Zhu H, Qi G, Fan Q, Ma Z. Wang H, et al. Among authors: ma z. Pharmazie. 2012 Jan;67(1):80-5. Pharmazie. 2012. PMID: 22393836

8

[Thyroid transcription factor-1 level is associated with epidermal growth factor receptor mutation status in patients with advanced lung adenocarcinoma].

Niu Y, Wang H, Zhang G, Ma J, Wei B, Ma Z. Niu Y, et al. Among authors: ma j, ma z. Zhonghua Jie He He Hu Xi Za Zhi. 2014 Dec;37(12):919-23. Zhonghua Jie He He Hu Xi Za Zhi. 2014. PMID: 25609130 Chinese.

9

Pathological complete response to gefitinib in a 10-year-old boy with EGFR-negative pulmonary mucoepidermoid carcinoma: a case report and literature review.

Li S, Zhang Z, Tang H, He Z, Gao Y, Ma W, Chang Y, Wei B, Ma J, Liu K, Ma Z, Wang Q. Li S, et al. Among authors: ma w, ma j, ma z. Clin Respir J. 2017 May;11(3):346-351. doi: 10.1111/crj.12343. Epub 2015 Aug 6. Clin Respir J. 2017. PMID: 26148572 Review.

10

[Current Status and Development of Traditional Chemotherapy in Non-small Cell Lung Cancer under the Background of Targeted Therapy].

Zhang G, Wang H, Zhang M, Li P, Ma Z. Zhang G, et al. Among authors: ma z. Zhongguo Fei Ai Za Zhi. 2015 Sep 20;18(9):587-91. doi: 10.3779/j.issn.1009-3419.2015.09.10. Zhongguo Fei Ai Za Zhi. 2015. PMID: 26383984 Free PMC article. Review. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,666 results

Search Page

Filters